Although recent studies have shown distinct mechanisms for CCN downregulation in CML and that this inhibition occurs as a direct BCR-ABL kinase activity, the epigenetic mechanisms for CCN3 suppression had been poorly understood. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.